tobramycin has been researched along with Atypical Mycobacterial Infection, Disseminated in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Böttger, EC; Hobbie, SN; Ordway, DJ; Petrig, A; Sander, P; Selchow, P; Verma, D; Whittel, N | 1 |
| Arslan, N; Esen, N; Özkarataş, MH; Özkütük, AA | 1 |
| Afifi, A; De Lord, D; Rasool, S | 1 |
| Gui, J; Hong, CY; Li, JL; Liang, J; Wang, F | 1 |
| Biswas, A; Cadwgan, A; Halpern, J; Tan, BB | 1 |
| Bricaire, F; Caumes, E; Monsel, G; Roujeau, JC; Schneider, P; Veziris, N | 1 |
| Daines, BS; Sandoval, HP; Solomon, KD; Steed, LL; Vroman, DT | 1 |
| Akduman, L; Lee, DH; Oz, O; Smetana, SM | 1 |
| Lee, SB; Mohan, SK; Oliver, KM; Slomovic, AR; Strube, YN | 1 |
| Bergmann, JS; Boulet, B; Brown, BA; Fahle, GA; Plaunt, M; Wallace, RJ; Wanger, A; Witebsky, FG; Woods, GL | 1 |
| Campbell, I; Herzig, S; Rootman, DS; Suresh, PS | 1 |
1 review(s) available for tobramycin and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keratomileusis.
Topics: Amikacin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Indicators and Reagents; Keratomileusis, Laser In Situ; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myopia; Postoperative Complications; Staining and Labeling; Tobramycin | 2003 |
10 other study(ies) available for tobramycin and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
Apramycin Overcomes the Inherent Lack of Antimicrobial Bactericidal Activity in Mycobacterium abscessus.
Topics: Animals; Anti-Bacterial Agents; Mice; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Nebramycin | 2022 |
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tobramycin | 2023 |
Case of atypical cutaneous
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Cyclophosphamide; Diagnosis, Differential; Female; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Tobramycin; Treatment Outcome | 2019 |
[Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Culture Media; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Oxazolidinones; Sensitivity and Specificity; Tobramycin | 2013 |
Disseminated cutaneous Mycobacterium chelonae infection in an immunocompetent host.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Tobramycin; Treatment Outcome | 2010 |
Successful treatment of nodular lymphangitis due to Mycobacterium chelonae in two immunosuppressed patients.
Topics: Administration, Oral; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Injections, Intravenous; Lymphangitis; Male; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Tigecycline; Tobramycin; Treatment Outcome | 2011 |
A case of infected scleral buckle with Mycobacterium chelonae associated with chronic intraocular inflammation.
Topics: Anti-Bacterial Agents; Chronic Disease; Device Removal; Dexamethasone; Drug Therapy, Combination; Eye Infections, Bacterial; Glucocorticoids; Humans; Iridocyclitis; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Prosthesis-Related Infections; Reoperation; Scleral Buckling; Scleritis; Tobramycin | 2004 |
Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.
Topics: Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Quinolines; Surgical Flaps; Tobramycin | 2005 |
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Culture Media; Doxycycline; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Sulfamethoxazole; Tobramycin | 1999 |
Mycobacterium keratitis following hyperopic laser in situ keratomileusis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cornea; Drug Resistance, Microbial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Hyperopia; Keratitis; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Prednisolone; Tobramycin | 2001 |